QVIDTVM Management LLC
CIK
1912226
Location
THE WOODLANDS, TX
Portfolio Value
Micro
$45,366,688
Diversification
Moderately concentrated
Filing Date
Global Rank
#6,095
/ 8,578
▼ 19
Top Industry
Medical Devices
28.9%
3Y Alpha vs SPY
-16.8%
Period ended 3 months ago
Filed May 15, 2026 · 31d
17 quarters · since Dec 2021
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+10.8%
SPY
+77.5%
Annualised alpha
-17.6%
Max drawdown
−28.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
14 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
28.7%
+0.1 pts
Top 5
79.7%
+0.0 pts
Top 10
98.4%
−0.2 pts
HHI
1,704
Moderately concentrated−117
Portfolio Trend
17 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 55.8% | $45,366,688 |
| Basic Materials | 15.0% | $12,181,885 |
| Communication Services | 7.7% | $6,295,949 |
| Consumer Cyclical | 7.6% | $6,217,918 |
| Technology | 7.0% | $5,722,873 |
| Consumer Defensive | 3.5% | $2,817,329 |
| Real Estate | 2.3% | $1,856,800 |
| Industrials | 1.1% | $908,800 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
4 positions
4 positions ·
$45,366,688 total
· Healthcare only
· as of Mar 31, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Healthcare
Industrials
Real Estate
Technology
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BIO |
Bio-Rad Laboratories, Inc.
Healthcare
|
Added | 83,732 | $23,340,295 | 51.45% | |
| SOLV |
Solventum Corp
Healthcare
|
Reduced | 265,615 | $17,344,659 | 38.23% | |
| XRAY |
DENTSPLY SIRONA Inc.
Healthcare
|
Reduced | 385,409 | $4,470,744 | 9.85% | |
| LAB |
Standard Biotools Inc.
Healthcare
|
Held | 229,338 | $210,990 | 0.47% |